Recon Regulatory Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch byJosh SandbergSeptember 10, 2026
Recon Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures byTim AllenSeptember 10, 2026
Financial Recon Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience byTim AllenSeptember 8, 2026
Recon Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference byNoah SimmonsSeptember 1, 2026
Recon Top Stories Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer byNoah SimmonsAugust 10, 2026
Financial Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook byJosh SandbergAugust 7, 2026
Financial Shoulder Innovations Announces Closing of up to $50 Million Credit Facility byTim AllenJune 29, 2026
Recon Regulatory Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem byTim AllenApril 27, 2026
Financial Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results byJosh SandbergMarch 10, 2026
Recon Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors byJosh SandbergMarch 2, 2026
